Private Equity
Los Angeles-based Westlake Village BioPartners, a venture firm focused on life sciences, has raised $320 million for its debut fund. Dr. Beth Seidenberg, a general partner at Kleiner Perkins and former chief medical officer and head of global development at Amgen and Dr. Sean Harper, executive vice president and head of R&D at Amgen, will lead Westlake’s investing activities. And, Scott Ryles, chief operating officer at Kleiner Perkins, will be Westlake's chief operating officer.
4 min read · 05 September 2018
1 min read · 05 September 2018
Brand Foundry Ventures has set out to raise for two funds, according to filings with the SEC.
1 min read · 04 September 2018
Exor Seeds has raised a $75 million venture-capital fund, according to a filing with the SEC.
1 min read · 04 September 2018
1 min read · 04 September 2018
Rosecliff Ventures has set out to raise a $250 million third venture-capital fund, according to a filing with the SEC.
1 min read · 31 August 2018
Boulder Ventures is targeting $60 million for a seventh fund, according to a regulatory document. Based in Boulder, Colorado, the firm invests in information technology and life sciences companies located in the Mid-Atlantic and Colorado.
1 min read · 31 August 2018
Quan Capital is seeking to raise $300 million for its second fund, according to an SEC filing. Based in China, Quan Capital is a venture firm that invests in healthcare, pharmaceutical and biotech startups.
1 min read · 31 August 2018
Powerplant Ventures is seeking to raise $100 million for its second fund, according to an SEC filing. Based in Manhattan Beach, California, the emerging-stage growth equity firm invests in consumer food, beverage, and foodservice companies.
1 min read · 30 August 2018
4 min read · 30 August 2018
